World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 33519937

Number of visits today: 6765

Number of downloads: 16706310

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Öman M, Wettergren Y, Odin E, Westermark S, Naredi P, Hemmingsson O, Taflin H. Pharmacokinetics of preoperative intraperitoneal 5-FU in patients with pancreatic ductal adenocarcinoma. Cancer Chemother Pharmacol 2021;88:619-31. [PMID: 34132895 DOI: 10.1007/s00280-021-04318-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]

For:

Öman M, Wettergren Y, Odin E, Westermark S, Naredi P, Hemmingsson O, Taflin H. Pharmacokinetics of preoperative intraperitoneal 5-FU in patients with pancreatic ductal adenocarcinoma. Cancer Chemother Pharmacol 2021;88:619-31. [PMID: 34132895 DOI: 10.1007/s00280-021-04318-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]

Number	Citing Articles
1	Toledo B, González-Titos A, Hernández-Camarero P, Perán M. A Brief Review on Chemoresistance; Targeting Cancer Stem Cells as an Alternative Approach. Int J Mol Sci 2023;24. [PMID: 36901917 DOI: 10.3390/ijms24054487] [Reference Citation Analysis]
2	Lee W, Song G, Bae H. Matairesinol Induces Mitochondrial Dysfunction and Exerts Synergistic Anticancer Effects with 5-Fluorouracil in Pancreatic Cancer Cells. Mar Drugs 2022;20:473. [PMID: 35892941 DOI: 10.3390/md20080473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3	Zeng X, Fan X, Fu C, Yang J, Tian J, Peng Q, Qin W, Wu Y, Omri A. Codelivery of Doxorubicin/PI3K Inhibitor Nanomicelle Linked with Phenylboronic Acid for Enhanced Cytotoxicity to Pancreatic Cancer. Journal of Nanomaterials 2022;2022:1-12. [DOI: 10.1155/2022/8758356] [Reference Citation Analysis]
4	Sugarbaker PH. After thirty years of experience with early postoperative intraperitoneal 5-fluorouracil now saying goodbye. Surgical Oncology 2022. [DOI: 10.1016/j.suronc.2022.101757] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5	Eftekhar SP, Kazemi S, Moghadamnia AA. Effect of thymoquinone on pharmacokinetics of 5-fluorouracil in rats and its effect on human cell line in vitro. Hum Exp Toxicol 2022;41:9603271221145422. [PMID: 36510676 DOI: 10.1177/09603271221145422] [Reference Citation Analysis]
6	Pu N, Yin H, Chen Q, Zhang J, Wu W, Lou W. Current status and future perspectives of clinical research in pancreatic cancer: Establishment of evidence by science. J Hepatobiliary Pancreat Sci 2021. [PMID: 34514722 DOI: 10.1002/jhbp.1045] [Reference Citation Analysis]